• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Social Capital Suvretta Holdings Corp. III ordinary shares

    12/29/21 5:12:00 PM ET
    $DNAC
    Get the next $DNAC alert in real time by email
    SC 13G 1 d284085dsc13g.htm SC 13G SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. ___)*

     

     

    SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III

    (Name of Issuer)

    Class A Ordinary Shares, par value $0.0001 per share

    (Title of Class of Securities)

    G8253W109

    (CUSIP Number)

    December 23, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. G26507122

     

      (1)    

      Names of reporting persons

     

      Sculptor Capital LP

      (2)  

      Check the appropriate box if a member of a group (see instructions)

      (a)  ☐        (b)  ☒

     

      (3)  

      SEC use only

     

      (4)  

      Citizenship or place of organization

     

      Delaware

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)     

      Sole voting power

     

      0

       (6)   

      Shared voting power

     

      1,299,486

       (7)   

      Sole dispositive power

     

      0

       (8)   

      Shared dispositive power

     

      1,299,486

      (9)    

      Aggregate amount beneficially owned by each reporting person

     

      1,299,486

    (10)  

      Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

      Percent of class represented by amount in Row (9)

     

      5.07%

    (12)  

      Type of reporting person (see instructions)

     

      IA


    CUSIP No. G8253W109

     

      (1)    

      Names of reporting persons

     

      Sculptor Capital II LP

      (2)  

      Check the appropriate box if a member of a group (see instructions)

      (a)  ☐        (b)  ☒

     

      (3)  

      SEC use only

     

      (4)  

      Citizenship or place of organization

     

      Delaware

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)     

      Sole voting power

     

      0

       (6)   

      Shared voting power

     

      1,299,486

       (7)   

      Sole dispositive power

     

      0

       (8)   

      Shared dispositive power

     

      1,299,486

      (9)    

      Aggregate amount beneficially owned by each reporting person

     

      1,299,486

    (10)  

      Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

      Percent of class represented by amount in Row (9)

     

      5.07%

    (12)  

      Type of reporting person (see instructions)

     

      IA


    CUSIP No. G8253W109

     

      (1)    

      Names of reporting persons

     

      Sculptor Capital Holding Corp.

      (2)  

      Check the appropriate box if a member of a group (see instructions)

      (a)  ☐        (b)  ☒

     

      (3)  

      SEC use only

     

      (4)  

      Citizenship or place of organization

     

      Delaware

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)     

      Sole voting power

     

      0

       (6)   

      Shared voting power

     

      1,299,486

       (7)   

      Sole dispositive power

     

      0

       (8)   

      Shared dispositive power

     

      1,299,486

      (9)    

      Aggregate amount beneficially owned by each reporting person

     

      1,299,486

    (10)  

      Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

      Percent of class represented by amount in Row (9)

     

      5.07%

    (12)  

      Type of reporting person (see instructions)

     

      CO


    CUSIP No. G8253W109

     

      (1)    

      Names of reporting persons

     

      Sculptor Capital Holding II LLC

      (2)  

      Check the appropriate box if a member of a group (see instructions)

      (a)  ☐        (b)  ☒

     

      (3)  

      SEC use only

     

      (4)  

      Citizenship or place of organization

     

      Delaware

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)     

      Sole voting power

     

      0

       (6)   

      Shared voting power

     

      1,299,486

       (7)   

      Sole dispositive power

     

      0

       (8)   

      Shared dispositive power

     

      1,299,486

      (9)    

      Aggregate amount beneficially owned by each reporting person

     

      1,299,486

    (10)  

      Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

      Percent of class represented by amount in Row (9)

     

      5.07%

    (12)  

      Type of reporting person (see instructions)

     

      CO


    CUSIP No. G8253W109

     

      (1)    

      Names of reporting persons

     

      Sculptor Capital Management, Inc.

      (2)  

      Check the appropriate box if a member of a group (see instructions)

      (a)  ☐        (b)  ☒

     

      (3)  

      SEC use only

     

      (4)  

      Citizenship or place of organization

     

      Delaware

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)     

      Sole voting power

     

      0

       (6)   

      Shared voting power

     

      1,299,486

       (7)   

      Sole dispositive power

     

      0

       (8)   

      Shared dispositive power

     

      1,299,486

      (9)    

      Aggregate amount beneficially owned by each reporting person

     

      1,299,486

    (10)  

      Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

      Percent of class represented by amount in Row (9)

     

      5.07%

    (12)  

      Type of reporting person (see instructions)

     

      CO


    CUSIP No. G8253W109

     

      (1)    

      Names of reporting persons

     

      Sculptor Master Fund, Ltd.

      (2)  

      Check the appropriate box if a member of a group (see instructions)

      (a)  ☐        (b)  ☒

     

      (3)  

      SEC use only

     

      (4)  

      Citizenship or place of organization

     

      Cayman Islands

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)     

      Sole voting power

     

       (6)   

      Shared voting power

     

      605,546

       (7)   

      Sole dispositive power

     

       (8)   

      Shared dispositive power

     

      605,546

      (9)    

      Aggregate amount beneficially owned by each reporting person

     

      605,546

    (10)  

      Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

      Percent of class represented by amount in Row (9)

     

      2.36%

    (12)  

      Type of reporting person (see instructions)

     

      CO


    CUSIP No. G8253W109

     

      (1)    

      Names of reporting persons

     

      Sculptor Special Funding, LP

      (2)  

      Check the appropriate box if a member of a group (see instructions)

      (a)  ☐        (b)  ☒

     

      (3)  

      SEC use only

     

      (4)  

      Citizenship or place of organization

     

      Cayman Islands

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)     

      Sole voting power

     

       (6)   

      Shared voting power

     

      605,546

       (7)   

      Sole dispositive power

     

       (8)   

      Shared dispositive power

     

      605,546

      (9)    

      Aggregate amount beneficially owned by each reporting person

     

      605,546

    (10)  

      Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

      Percent of class represented by amount in Row (9)

     

      2.36%

    (12)  

      Type of reporting person (see instructions)

     

      CO


    CUSIP No. G8253W109

     

      (1)    

      Names of reporting persons

     

      Sculptor Credit Opportunities Master Fund, Ltd.

      (2)  

      Check the appropriate box if a member of a group (see instructions)

      (a)  ☐        (b)  ☒

     

      (3)  

      SEC use only

     

      (4)  

      Citizenship or place of organization

     

      Cayman Islands

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)     

      Sole voting power

     

       (6)   

      Shared voting power

     

      179,399

       (7)   

      Sole dispositive power

     

       (8)   

      Shared dispositive power

     

      179,399

      (9)    

      Aggregate amount beneficially owned by each reporting person

     

      179,399

    (10)  

      Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

      Percent of class represented by amount in Row (9)

     

      0.70%

    (12)  

      Type of reporting person (see instructions)

     

      CO


    CUSIP No. G8253W109

     

      (1)    

      Names of reporting persons

     

      Sculptor SC II LP

      (2)  

      Check the appropriate box if a member of a group (see instructions)

      (a)  ☐        (b)  ☒

     

      (3)  

      SEC use only

     

      (4)  

      Citizenship or place of organization

     

      Delaware

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)     

      Sole voting power

     

       (6)   

      Shared voting power

     

      445,142

       (7)   

      Sole dispositive power

     

       (8)   

      Shared dispositive power

     

      445,142

      (9)    

      Aggregate amount beneficially owned by each reporting person

     

      445,142

    (10)  

      Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

      Percent of class represented by amount in Row (9)

     

      1.74%

    (12)  

      Type of reporting person (see instructions)

     

      CO


    CUSIP No. G8253W109

     

      (1)    

      Names of reporting persons

     

      Sculptor Enhanced Master Fund, Ltd.

      (2)  

      Check the appropriate box if a member of a group (see instructions)

      (a)  ☐        (b)  ☒

     

      (3)  

      SEC use only

     

      (4)  

      Citizenship or place of organization

     

      Cayman Islands

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with:

       (5)     

      Sole voting power

     

       (6)   

      Shared voting power

     

      69,399

       (7)   

      Sole dispositive power

     

       (8)   

      Shared dispositive power

     

      69,399

      (9)    

      Aggregate amount beneficially owned by each reporting person

     

      69,399

    (10)  

      Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    (11)  

      Percent of class represented by amount in Row (9)

     

      0.27%

    (12)  

      Type of reporting person (see instructions)

     

      CO


      •  

    Sculptor Capital LP (“Sculptor”), a Delaware limited partnership, is the principal investment manager to a number of private funds and discretionary accounts (collectively, the “Accounts”).

     

      •  

    Sculptor Capital II LP (“Sculptor-II”), a Delaware limited partnership that is wholly owned by Sculptor, also serves as the investment manager to certain of the Accounts. The Ordinary Shares reported in this Schedule 13G are held in the Accounts managed by Sculptor and Sculptor-II.

     

      •  

    Sculptor Capital Holding Corporation (“SCHC”), a Delaware corporation, serves as the general partner of Sculptor.

     

      •  

    Sculptor Capital Holding II LLC (“SCHC-II”), a Delaware limited liability company that is wholly owned by Sculptor, serves as the general partner of Sculptor-II.

     

      •  

    Sculptor Capital Management, Inc. (“SCU”), a Delaware limited liability company, is a holding company that is the sole shareholder of SCHC and the ultimate parent company of Sculptor and Sculptor-II.

     

      •  

    Sculptor Master Fund, Ltd. (“SCMF”) is a Cayman Islands company. Sculptor is the investment adviser to SCMF.

     

      •  

    Sculptor Special Funding, LP (“NRMD”) is a Cayman Islands exempted limited partnership that is wholly owned by SCMF.

     

      •  

    Sculptor Credit Opportunities Master Fund, Ltd. (“SCCO”) is a Cayman Islands company. Sculptor is the investment adviser to SCCO.

     

      •  

    Sculptor SC II LP (“NJGC”) is a Delaware limited partnership. Sculptor-II is the investment adviser to NJGC.

     

      •  

    Sculptor Enhanced Master Fund, Ltd. (“SCEN”) is a Cayman Islands company. Sculptor is the investment adviser to SCEN.

     

      •  

    The address of the principal business offices of Sculptor, Sculptor-II, SCHC, SCHC-II, SCU, SCMF, NRMD, SCEN, SCCO and NJGC is 9 West 57 Street, 39 Floor, New York, NY 10019.

    Item 1(a) Name of issuer:

    SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III, a Cayman Islands exempted company (the “Issuer”)

    Item 1(b) Address of issuer’s principal executive offices:

    2850 W. Horizon Ridge Parkway, Suite 200

    Henderson, NV 89052

    2(a) Name of person filing:

    Sculptor Capital LP

    2(b) Address or principal business office or, if none, residence:

    9 West 57th Street, New York, New York 10019

    2(c) Citizenship:

    Delaware

    2(d) Title of class of securities:

    Class A Ordinary Shares, par value $0.0001 per share (the “Ordinary Shares”)

    2(e) CUSIP No.: G8253W109


    Item 3.

    If this statement is filed pursuant to §§240.13d–1(b) or 240.13d–2(b) or (c), check whether the person filing is a:

     

    (a)    [ ]    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)    [ ]    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)    [ ]    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)    [ ]    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a–8);
    (e)    [_]    An investment adviser in accordance with §240.13d–1(b)(1)(ii)(E);
    (f)    [ ]    An employee benefit plan or endowment fund in accordance with §240.13d–1(b)(1)(ii)(F);
    (g)    [ ]    A parent holding company or control person in accordance with §240.13d–1(b)(1)(ii)(G);
    (h)    [ ]    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)    [ ]    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a–3);
    (j)    [ ]    A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
    (k)    [ ]    Group, in accordance with §240.13d–1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J), please specify the type of institution: ________________________________

     

    Item 4.

    Ownership

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

    (a) Amount beneficially owned: 1,299,486

    (b) Percent of class: 5.07%


    SCHEDULE 13G

    (c) Number of shares as to which the person has:

    (i) Sole power to vote or to direct the vote 0.

    (ii) Shared power to vote or to direct the vote 1,299,486

    (iii) Sole power to dispose or to direct the disposition of 0

    (iv) Shared power to dispose or to direct the disposition of 1,299,486

    Sculptor and Sculptor-II serve as the principal investment managers to the Accounts and thus may be deemed beneficial owners of the Ordinary Shares in the Accounts managed by Sculptor and Sculptor-II. SCHC-II serves as the sole general partner of Sculptor-II and is wholly owned by Sculptor. SCHC serves as the sole general partner of Sculptor. As such, SCHC and SCHC-II may be deemed to control Sculptor as well as Sculptor-II and, therefore, may be deemed to be the beneficial owners of the Ordinary Shares reported in this Schedule 13G. SCU is the sole shareholder of SCHC, and, for purposes of this Schedule 13G, may be deemed a beneficial owner of the Ordinary Shares reported herein.

    The percentages reported in this Schedule 13G have been calculated based on the Issuer’s initial public offering of 25,640,000 Ordinary Shares, as set forth in the Issuer’s 10-Q filed November 15, 2021.

     

    Item 5.

    Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ].

    Dissolution of a group requires a response to this item.

     

    Item 6.

    Ownership of More than 5 Percent on Behalf of Another Person.

    See Item 4.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    N/A

     

    Item 8.

    Identification and Classification of Members of the Group.

    See Item 4.

     

    Item 9.

    Notice of Dissolution of Group.

    N/A

     

    Item 10.

    Certifications

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect other than activities solely in connection with a nomination under §240.14a-11.


    Signatures

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: December 29, 2021   

    SCULPTOR CAPITAL LP

    By: Sculptor Capital Holding Corporation, its General Partner

    Signature:/s/ Wayne Cohen

    Name: Wayne Cohen

    Title: President and Chief Operating Officer

      

    SCULPTOR CAPITAL II LP

    By: Sculptor Capital Holding II LLC, its General Partner

    By: Sculptor Capital LP, its Member

    By: Sculptor Capital Holding Corporation, its General Partner

    Signature:/s/ Wayne Cohen

    Name: Wayne Cohen

    Title: President and Chief Operating Officer

      

    SCULPTOR CAPITAL HOLDING CORPORATION

    Signature:/s/ Wayne Cohen

    Name: Wayne Cohen

    Title: President and Chief Operating Officer

      

    SCULPTOR CAPITAL HOLDING II LLC

    Signature:/s/ Wayne Cohen

    Name: Wayne Cohen

    Title: President and Chief Operating Officer

      

    SCULPTOR CAPITAL MANAGEMENT, INC.

    Signature:/s/ Wayne Cohen

    Name: Wayne Cohen

    Title: President and Chief Operating Officer

      

    SCULPTOR MASTER FUND, LTD.

    By: Sculptor Capital LP, its investment manager

    By: Sculptor Capital Holding Corporation, its General Partner

    Signature:/s/ Wayne Cohen

    Name: Wayne Cohen

    Title: President and Chief Operating Officer

      

    SCULPTOR SPECIAL FUNDING, LP

    By: Sculptor Capital LP, its investment manager

    By: Sculptor Capital Holding Corporation, its General Partner

    Signature:/s/ Wayne Cohen

    Name: Wayne Cohen

    Title: President and Chief Operating Officer

      

    SCULPTOR ENHANCED MASTER FUND, LTD.

    By: Sculptor Capital LP, its Investment Manager

    By: Sculptor Capital Holding Corporation, its General Partner

    Signature:/s/ Wayne Cohen

    Name: Wayne Cohen

    Title: President and Chief Operating Officer

      

    SCULPTOR CREDIT OPPORTUNITIES MASTER FUND, LTD.

    By: Sculptor Capital LP, its Investment Manager

    By: Sculptor Capital Holding Corporation, its General Partner

    Signature:/s/ Wayne Cohen

    Name: Wayne Cohen

    Title: President and Chief Operating Officer

      

    SCULPTOR SC II LP

    By: Sculptor Capital II LP, its Investment Manager

    By: Sculptor Capital Holding II LLC, its General Partner

    By: Sculptor Capital LP, its Member

    By: Sculptor Capital Holding Corporation, its General Partner

    Signature:/s/ Wayne Cohen

    Name: Wayne Cohen

    Title: President and Chief Operating Officer

    Get the next $DNAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DNAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DNAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Weger Mary

    4 - PROKIDNEY CORP. (0001850270) (Issuer)

    1/18/23 4:14:18 PM ET
    $DNAC

    SEC Form 4 filed by Weber Darin J.

    4 - PROKIDNEY CORP. (0001850270) (Issuer)

    1/18/23 4:13:35 PM ET
    $DNAC

    SEC Form 4 filed by Mckenzie Libbie Parker

    4 - PROKIDNEY CORP. (0001850270) (Issuer)

    1/18/23 4:12:58 PM ET
    $DNAC

    $DNAC
    SEC Filings

    View All

    SEC Form 424B3 filed by Social Capital Suvretta Holdings Corp. III

    424B3 - PROKIDNEY CORP. (0001850270) (Filer)

    1/20/23 6:52:24 AM ET
    $DNAC

    Social Capital Suvretta Holdings Corp. III filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PROKIDNEY CORP. (0001850270) (Filer)

    1/19/23 4:18:53 PM ET
    $DNAC

    SEC Form 424B3 filed by Social Capital Suvretta Holdings Corp. III

    424B3 - PROKIDNEY CORP. (0001850270) (Filer)

    1/11/23 4:26:35 PM ET
    $DNAC

    $DNAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III

    ProKidney Class A ordinary shares to begin trading on Nasdaq under the ticker symbol "PROK" on July 12, 2022 ProKidney receives total gross proceeds of approximately $597 million, expected to fund Phase 3 study of REACT™PIPE is led by a $125 million investment from Social Capital, with an additional $50 million from existing ProKidney investors, approximately $30 million from Suvretta Capital's Averill strategy and the remaining $370 million from institutional investors and family offices Proceeds will fund ongoing Phase 2 and 3 development program for ProKidney's lead cell therapy candidate, REACT™, accelerate manufacturing scale-out, and ultimately prepare for its global commercial launch

    7/12/22 8:00:00 AM ET
    $DNAC

    Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of Shareholders

    Social Capital Suvretta Holdings Corp. III ("SCS") today announced that it will reconvene the Extraordinary General Meeting of its shareholders to vote on the Business Combination Agreement, dated as of January 18, 2022, by and between SCS and ProKidney LP, a limited partnership organized under the laws of Ireland ("ProKidney"), acting through its general partner ProKidney GP Limited, a private limited company incorporated under the laws of Ireland, and the transactions contemplated thereby (the "Business Combination") on July 11, 2022 at 8:30 a.m., Eastern Time, physically at the offices of Wachtell, Lipton, Rosen & Katz located at 51 West 52nd Street, New York, New York 10019, and virtual

    7/8/22 7:36:00 PM ET
    $DNAC

    ProKidney Corroborates the Mechanism of Action of REACT™ with Cell Marker Analysis in Patients with Diabetic Chronic Kidney Disease

    WINSTON-SALEM, N.C., June 23, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease (CKD) and the prevention of end-stage renal disease (ESRD) requiring dialysis or transplant, today published data from a patient study confirming the mechanistic action of its lead candidate REACT™ with cell marker analysis. "Renal Autologous Cell Therapy to Stabilize Function in Diabetes-Related Chronic Kidney Disease: Corroboration of Mechanistic Action with Cell Marker Analysis" by Joseph Stavas et. al. The paper, published in Kidney International Reports, describes observed improvements i

    6/23/22 8:00:00 AM ET
    $DNAC

    $DNAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Social Capital Suvretta Holdings Corp. III

    SC 13G - PROKIDNEY CORP. (0001850270) (Subject)

    9/12/22 5:17:13 PM ET
    $DNAC

    SEC Form SC 13D filed by Social Capital Suvretta Holdings Corp. III

    SC 13D - PROKIDNEY CORP. (0001850270) (Subject)

    7/22/22 4:39:52 PM ET
    $DNAC

    SEC Form SC 13D filed by Social Capital Suvretta Holdings Corp. III

    SC 13D - PROKIDNEY CORP. (0001850270) (Subject)

    7/22/22 4:34:01 PM ET
    $DNAC

    $DNAC
    Leadership Updates

    Live Leadership Updates

    View All

    ProKidney Appoints Libbie Parker McKenzie, MD, FASN as Chief Medical Officer

    WINSTON-SALEM, N.C., April 28, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease (CKD) and prevention of both end-stage renal disease (ESRD) and the need for dialysis, today announced the appointment of Libbie Parker McKenzie, MD, FASN as Chief Medical Officer. "On behalf of our entire team, I am excited to welcome Libbie to ProKidney. Her deep clinical, pharmacovigilance and regulatory affairs expertise will be instrumental to our continued success as we work to advance the development of our lead program, REACT®," said Tim Bertram, Ph.D., Chief Executive Officer of ProKidney. "In a

    4/28/22 8:00:00 AM ET
    $DNAC

    ProKidney Appoints Todd C. Girolamo as General Counsel

    WINSTON-SALEM, N.C., March 28, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on therapies for chronic kidney disease (CKD) and prevention of end-stage renal disease (ESRD) and need for dialysis, today announced the appointment of Todd C. Girolamo as General Counsel. "We are thrilled to welcome Todd to the ProKidney team in such an important role," said Tim Bertram, Ph.D., Chief Executive Officer of ProKidney. "His experience as both an attorney and capital markets professional will be important to our future success, as we move closer to becoming a public company through our proposed merger with SCS. I look forward to wor

    3/28/22 8:00:00 AM ET
    $DNAC

    $DNAC
    Financials

    Live finance-specific insights

    View All

    Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III

    ProKidney offers a first-of-its-kind, patented disease-modifying autologous cell therapy for treatment of chronic kidney disease ("CKD") Lead product candidate, REACT®, has potential to slow, stabilize, and even reverse decline in kidney function, delaying the onset of dialysis and potentially delivering significant cost savings to healthcare systems globally REACT® has received Regenerative Medicine Advanced Therapy ("RMAT") designation, as well as U.S. FDA and European Medicines Agency guidance, for its Phase 3 clinical program; Phase 3 trial launched in the United States on schedule in January 2022 Transaction values the combined company at an equity value of $2.64 billion post

    1/18/22 7:00:00 AM ET
    $DNAC
    $RPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care